Guest guest Posted November 18, 2009 Report Share Posted November 18, 2009 I guess the question I have is, why would the manufacturer of the chambers be hiding out on Panama? And why would they keep their money in Cypress. When you (the distributor) buys a chamber, you probably pay them in Cypress. If a chamber were to blow up or something, you would point the blame to Performance Hyperbarics and they would be under a tree in Panama unreachable by the law. That means while YOU may say the chamber is the safest in the market, the manufacturer has gone to great lengths to sheild themselves from any liability, in case something were to go wrong. They make the chambers in the US, they sell them in the US, and the marketing is done from the US (Hawaii). But they are 'Headquartered' in Panama thru a shell company nameed Performance Hyperbarics, Inc. There is no building they own in Panama and there are no employees working in Panama. If you google map (using the Satelite option) their address in Hawaii, you can see that it is a house. There is something REALLY FISHY going on here. > > > > From: G <gkuehn2@> > > Subject: Study: mHBOT ineffective for autism > > HDOTherapyforAutism > > Cc: neurohbot , medicaid > > Date: Tuesday, November 17, 2009, 1:16 AM > > > >  > > > > I just found this about 5 minutes ago and can't believe it. What it doesn't talk about is whether hbot at higher pressures with oxygen helps. The web page is centerforautsm. com > > Center for Autism and Related Disorders Study Finds Hyperbaric Oxygen Therapy Ineffective Treatment for Children with Autism > > Los Angeles, CA †" November 05, 2009 Research conducted by the Center for Autism and RelatedDisorders, Inc. (CARD), shines new light on the effects of a popular form of hyperbaric oxygen therapy(HBOT) treatment for children with autism and related disorders. The “Randomized Trial of HyperbaricOxygen Therapy for Children with Autism†study reveals that HBOT, consisting of 24% oxygen delivered at1.3 atmospheres of pressure, does not have a significant effect on symptoms of autism. This study was ledby Doreen Granpeesheh, PhD, BCBAâ€D; Tarbox, PhD, BCBAâ€D; Dennis R. Dixon, PhD; Arthur E.Wilke; S. , PsyD; and Bradstreet, MD, MD (H), FAAFP. It is published in thecurrent issue of Research in Autism Spectrum Disorders. > > > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.